Bullying Prevention Intervention for Adolescent Primary Care Patients

Description

The purpose of this randomized controlled study is to evaluate acceptability and feasibility, and to gather preliminary data about efficacy, of "iPACT" (intervention to Prevent Adolescent Cyber-victimization with Text messages), a brief in-clinic introductory session + longitudinal automated text-message-based secondary prevention program for adolescents with a history of past-year cyber-victimization presenting to a pediatric clinic for well-child visits.

Study Start Date

March, 06 2018

Estimated Completion Date

October 2018

Interventions

  • Other: Control: Enhanced Usual Care (EUC)
  • Behavioral: iPACT Intervention

Study ID

Rhode Island Hospital -- R21HD088739

Status

Unknown

Trial ID

NCT03467009

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

50

Sponsor

Rhode Island Hospital

Inclusion Criteria

  • presenting to Hasbro Children's pediatric clinic
  • being mentally and physically able to assent
  • being English-speaking
  • having a consentable parent present
  • self-reporting cyber-victimization (defined as endorsing >1 past-year episode of technology-mediated victimization)

Exclusion Criteria

  • being cognitively or emotionally unable to take part in the intervention as determined by the pediatric attending clinician
  • suspected by clinical staff of being a victim of child abuse
  • currently incarcerated or under police custody

Gender

All

Ages

13 Years to 17 Years

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Rhode Island Hospital - Providence, Rhode Island 104.1 miles Megan L Ranney MD MPH 401-444-2557 mranney@lifespan.org

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.